In our study, undetected hypermutator or ultramutator cancers could have contributed to the mutation burden association, although the frequencies of MSI and POLE mutations that we recorded were typical of other studies,4 and we identified a monotonic relationship between mutation burden quartile and relapse-free survival. The gene discussed is POLE; the disease is cancer.